Gabelli & Co Investment Advisers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-6,700
Closed -$532K – 247
2022
Q4
$532K Hold
6,700
– – 0.11% 114
2022
Q3
$406K Hold
6,700
– – 0.05% 222
2022
Q2
$367K Hold
6,700
– – 0.05% 257
2022
Q1
$506K Hold
6,700
– – 0.07% 206
2021
Q4
$500K Hold
6,700
– – 0.07% 209
2021
Q3
$315K Buy
+6,700
New +$291K 0.04% 287

Other funds holding ACLS

Gabelli & Co Investment Advisers's ACLS Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Axcelis (ACLS) in Q1 2023, closing a stake of 6,700 shares — an estimated $532K sold.

Gabelli & Co Investment Advisers first reported a position in ACLS in Q3 2021 and held it in 6 quarters. The position peaked at $532K in Q4 2022. 378 funds tracked by Wall St. Rank hold ACLS as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining Axcelis position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 6,700 Axcelis shares in Q1 2023, an estimated $532K.
  • Gabelli & Co Investment Advisers first reported a position in Axcelis in Q3 2021 and held it in 6 quarters.
  • Gabelli & Co Investment Advisers's Axcelis position peaked at $532K in Q4 2022.
  • 378 funds tracked by Wall St. Rank held Axcelis as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.